foxo4 dri senolytic human trial 2024 2025 The peptide in a conformation (D-amino acids in a retro-reversed sequence), henceforth named FOXO4-DRI, competes with FOXO4 for p53 binding in a dose-dependent manner and doing so with higher affinity Bacteriostatic Water Reconstitution Solution WADA publishes 2023 Prohibited Colour:Ocean Blue
Pay in 4 interest-free payments of $7.49 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 9 - Sep 14